KIEUHAN PHAM: Open Payments
NPI 1497093256 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,430 in 109 payments from 21 companies in 2025. Trend: 2023 $1,615 · 2024 $1,395 · 2025 $2,430
Food & beverage: $2,346Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $610 |
| Janssen Biotech, Inc. | 14 | $360 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $327 |
| Ardelyx, Inc. | 3 | $143 |
| Madrigal Pharmaceuticals | 5 | $137 |
| Lilly USA, LLC | 4 | $106 |
| QOL Medical, LLC | 4 | $98 |
| GENZYME CORPORATION | 5 | $96 |
| Aimmune Therapeutics, Inc. | 4 | $86 |
| Enterra Medical, Inc. | 1 | $80 |
Products named: TREMFYA, ENTYVIO, RINVOQ, CREON, DUPIXENT, IBSRELA, REZDIFFRA, OMVOH.
Industry payments across OK — which companies pay providers there.
